Skip to content

DR.ROBERTO SALGADO

Active Private limited companyfounded 2006active for 20 yearsOostberg 56, 9140 TemseKBO/BCE: BE 0883.268.241

Lifetime

19 annual accounts with figures on one time axis, 20 filings since 2006
peak of €324,197 in 2019
€213,011▲ 42.2%
peak of €165,542 in 2019
€110,108▲ 93.1%
peak of €787,113 in 2021
€517,369▼ 15.3%
€201,885▼ 14.7%
Board3 names since 2006
3 directors and 2 others
Documentsfilings and deeds
12-06-202649 days before the deadline
2025micro format
Gross margin from €149,755 to €213,011Result from €57,022 to €110,108Dividend €203,765Equity from €611,027 to €517,369Cash from €113,430 to €53,227

Key points

from the 2025 annual accounts

Equity

€517,369 ▼ 15.3%
611,0272024+110,108Profit-203,765Dividend517,3692025

DR.ROBERTO SALGADO paid out €203,765 in dividends. That is 185% of the 2025 profit.

Result

€110,108 ▲ 93.1%
€57,0002024€110,0002025

The result rose in 2025 from €57,022 to €110,108.

Turnover

≈ €400,000 estimated

The micro format states no turnover.

Liquidity

3.10 was 4.82 in 2024

Short-term debts rose from €53,947 to €54,804.

Filings

20 annual accounts since 2006
AprilJune31 JulyOctober2010201520202025

Two of the last ten came late. The 2016 accounts came in latest, 38 days after the end of the period.

Position in the sector

€517,369

More equity than 82% of companies in human health. The sector median is €125,227, over 21,375 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,149 companies had the same profile as DR.ROBERTO SALGADO has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,149 companies, not a prediction for DR.ROBERTO SALGADO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 29-08-2006
Manager
Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0883268241
(director) and (director) reappointed General meeting of 02-03-2023 · Gazette deed
(manager) and (manager) reappointed General meeting of 10-01-2019 · Gazette deed
appointed as manager General meeting of 10-11-2011 · Gazette deed
All 34 events

Comparable companies

same main activity, similar in size and age
Company
DR.ROBERTO SALGADO Temse €719,254 €213,011 71.9% -
DICENTRA Ghent €739,769 €216,033 67.3% -
DR. C. GYSBRECHTS Ronse €785,588 €227,598 92.5% -
DR. LEPERCQUE SABINE, NEUS- , KEEL- , EN OORHEELKUNDE-REVALIDATIE Merelbeke-Melle €769,882 €205,696 90.2% -
DR. DE LAERE SYLVIE Aalst €728,031 €190,432 76.7% -
DR. RASQUIN-DR. VAN LANGENHOVE Destelbergen €815,769 €197,795 98.2% -
Dr. Annelies Krikilion, gynaecologie - verloskunde Ninove €789,857 €204,813 98.7% -

These companies have the same main activity as DR.ROBERTO SALGADO: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €728,000 and €816,000, founded between 2004 and 2009.

Official details

Source: KBO
Status
Active since 01-09-2006Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment unit
2.202.066.0869140 Temse, since 29-08-2006
Financial year end
31 December
Peppol
Reachable since 15-09-2025
Company details

Annual accounts 2025

€719,254▼ 15.2%
Filing
Filed on 12-06-2026, 49 days before the end of the filing period
Financials

Insights on DR.ROBERTO SALGADO

DR.ROBERTO SALGADO files the micro format. That format states no turnover. The gross margin rose from €61,775 in 2007 to €213,011 in 2025.

The balance sheet grew most from 2010 to 2012 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR.ROBERTO SALGADO

What is the company number of DR.ROBERTO SALGADO?
The company number of DR.ROBERTO SALGADO is 0883.268.241. The VAT number is the same number with BE in front: BE 0883.268.241.
Where is DR.ROBERTO SALGADO based?
The registered office is at Oostberg 56, 9140 Temse.Company details
What does DR.ROBERTO SALGADO do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR.ROBERTO SALGADO?
DR.ROBERTO SALGADO is a private limited company (BV).
When was DR.ROBERTO SALGADO founded?
DR.ROBERTO SALGADO was founded on 01-09-2006.
Is DR.ROBERTO SALGADO still active?
Yes, DR.ROBERTO SALGADO is an active enterprise in the KBO register.
What is the turnover of DR.ROBERTO SALGADO?
The turnover in financial year 2025 is about €400,000. This figure is estimated from the gross margin of €213,011 and 40 comparable companies (NACE 86220). It probably lies between €340,000 and €530,000.Financials
Is DR.ROBERTO SALGADO profitable?
In financial year 2025, DR.ROBERTO SALGADO made a profit of €110,108.
Where can I find the annual accounts of DR.ROBERTO SALGADO?
DR.ROBERTO SALGADO filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR.ROBERTO SALGADO due?
DR.ROBERTO SALGADO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.